Mantle Cell Lymphoma — Trials

Mantle Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

706 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 180
Recruiting: 93
Ph III recruiting: 6
Growth YoY: —
Industry share: 26%
Top sponsor: City of Hope Medical Center
Termination share: 35.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (121)

clinicaltrialsPublishedShowing 51–57 of 57 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05910801	Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma(V-MIND)	recruiting	Phase 2	100	Academic and Community Cancer Research UnitedOTHER	1	Nov 18, 2024	clinicaltrials
NCT06341556	A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma	recruiting	Phase 2	52	Fudan UniversityOTHER	1	Sep 4, 2024